|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/08 | |
| A61K 47/12 | |||
| A61K 47/18 | |||
| A61K 9/48 | |||
| A61K 31/216 | |||
| A61K 31/351 | |||
| A61K 31/65 | |||
| A61K 31/7036 |
| (11) | Patento numeris | 2964193 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14714013.1 |
| Europos patento paraiškos padavimo data | 2014-03-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-12-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/020763 |
| Data | 2014-03-05 |
| (87) | Numeris | WO 2014/138241 |
| Data | 2014-09-12 |
| (30) | Numeris | Data | Šalis |
| 201361772927 P | 2013-03-05 | US | |
| 201461925443 P | 2014-01-09 | US |
| (72) |
CARL, Stephen, M., US
VRETTOS, John, Stanley, US
STERN, William, US
|
| (73) |
Enteris BioPharma, Inc.,
83 Fulton Street, Boonton, NJ 07005,
US
|
| (54) | PHARMACEUTICALS FOR ORAL DELIVERY |
| PHARMACEUTICALS FOR ORAL DELIVERY |